.webp&w=384&q=75){kind=logo}
Loading, please wait...
Loading, please wait...
Randomized and implementation studies support primary high-risk HPV testing as an effective cervical-cancer screening strategy, with greater sensitivity for clinically relevant cervical precancer than cytology alone. HPV-based screening can extend the interval between negative screens while maintaining strong protection against cervical cancer, provided abnormal results are triaged and followed appropriately. For gynecologists, the most important operational issue is the pathway after a positive HPV result. Genotyping, reflex cytology, colposcopy and treatment thresholds need to be aligned with the screening framework being used. Screening programs therefore require not only accurate tests but strong recall and referral systems. In resource-limited settings, simplified HPV-based approaches may improve reach, but program design must consider local laboratory capacity, affordability and loss to follow-up.
Read summarized clinical updates, watch expert medical content, and earn CME certifications right from your smartphone.
Open your smartphone camera to scan and install.
Randomized and implementation studies support primary high-risk HPV testing as an effective cervical-cancer screening strategy, with greater sensitivity for clinically relevant cervical precancer than cytology alone. HPV-based screening can extend the interval between negative screens while maintaining strong protection against cervical cancer, provided abnormal results are triaged and followed appropriately. For gynecologists, the most important operational issue is the pathway after a positive HPV result. Genotyping, reflex cytology, colposcopy and treatment thresholds need to be aligned with the screening framework being used. Screening programs therefore require not only accurate tests but strong recall and referral systems. In resource-limited settings, simplified HPV-based approaches may improve reach, but program design must consider local laboratory capacity, affordability and loss to follow-up.
Today
The phase 3 ACACIA-HCM trial reveals that aficamten improves cardiac structure, diastolic relaxation, functional capacity, and symptom burden in symptomatic nonobstructive hypertrophic cardiomyopathy, marking a major milestone in targeted myosin inhibition.
6 days back
A clinical study shows that automated breast ultrasound paired with artificial intelligence accurately classifies BIRADS 3-4 lesions, reaching 95% sensitivity and 79% specificity. This diagnostic advance promises to reduce unnecessary core needle biopsies and refine clinical workflows in breast imaging.
3 weeks back
Researchers have engineered freestanding hierarchical-porous BCZT thin films that resist cracking and enhance ultrasonic energy harvesting in soft tissue. Achieving high piezoelectric output and acoustic matching, this lead-free material offers transformative potential for implantable bioelectronics.
Last week
A novel pathology-adaptive surface engineering strategy uses functionalized plasma polymer coatings to selectively modulate AGE adsorption, reducing oxidative stress and restoring bone formation in diabetic and aging microenvironments.
3 weeks back
A breakthrough study identifies the Klotho/PKCα/CUX1/SPARC/TGFβ-RII axis as a critical driver of podocyte mitochondrial injury and ferroptosis in diabetic kidney disease, unveiling promising molecular targets to halt renal disease progression.
6 days back
